The group has posted consolidated net profit/(loss) for the period after minority interest of INR592.665 million for the quarter ended June 30, 2009 as compared to INR448.875 million for the quarter ended June 30, 2008. Total Income has increased from INR 1795.717 million for the quarter ended June 30, 2008 to INR2308.002 million for the quarter ended June 30, 2009.
OCI is engaged in the design, development, manufacture and marketing of medical electronic devices and health care products, in both invasive and non-invasive segments.